// App-Quantinova.ai

4524 : Adjuvant versus neoadjuvant chemotherapy for muscle-invasive bladder cancer (MIBC): Analysis of the National Cancer Database (NCDB).

Researchers

Presenter

  • Guru Sonpavde

Principal Investigators

  • Rebecca A. Nelson

  • Quoc-Dien Trinh

  • Neeraj Agarwal

  • Jeffrey Nix

  • Steven Kardos

  • Joaquim Bellmunt

  • Toni K. Choueiri

  • Sumanta K. Pal

Medical Centers

  • The University of Alabama Birmingham Comprehensive Cancer Center, Birmingham, AL

  • City of Hope, Duarte, CA

  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

  • University of Alabama at Birmingham, Birmingham, AL

  • Dana-Farber Cancer Institute, Boston, MA

  • Dana-Farber/Brigham and Women's Cancer Center, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved